Translate:

Baker McKenzie is advising the French supplier of industrial gases group Air Liquide on the planned sale of the Schülke Group to the Swedish financial investor EQT.

In a bidding process for the sale of Schülke, EQT prevailed as bidder. The sale is subject to labour law consultations and regulatory approvals. The parties have agreed not to disclose the transaction volume.

An international team of Baker McKenzie lawyers is advising Air Liquide on the legal aspects of the transaction. The advice included the preparation and support of the bidding process and the drafting of contracts and negotiations with several bidders as well as the carve-out of Schülke from the Air Liquide Group.

"The transaction is a complete success for our client and for us. With a broad and seasoned team and full commitment across our practice groups and offices, we were able to provide Air Liquide with efficient support in all jurisdictions and legal areas involved - despite the difficult conditions in the current corona crisis", comments Dr. Florian Kästle, lead partner of the transaction.

In 2019, Baker McKenzie already advised Schülke on the sale of its Technical Biocides division to Vink Che-micals.

Schülke & Mayr GmbH (today: Schülke), founded in Hamburg in 1889, is a leading international company in the fields of hygiene and infection prevention. It supplies disinfectants, antiseptics, preservatives, biocides, medical skin care products, active deodorant ingredients and system cleaners. Schülke employs more than 1,250 people worldwide, sells its products in more than 100 countries and produces in Germany, France and Brazil.

Air Liquide is the global market leader in gases, technologies and services for industry and health. With more than 50,000 employees in 80 countries, Air Liquide supplies more than 2 million customers and patients with oxygen, nitrogen, hydrogen and other gases.

Advisors to Air Liquide:
Baker McKenzie

Lead:

Corporate/M&A: Dr. Florian Kästle (partner, Frankfurt), Ulrich Weidemann (counsel, Frankfurt)

Team:

Corporate/M&A: Andrea Ziegler (partner, Frankfurt), Alain Sauty de Chalon (partner, Paris), Friederike Göretzlehner, Jessica Köhler, Dr. Kathrin Weber, Esther Xiang (all associates, Frankfurt), Auriane Wessels (associate, Paris)
Pharma: Dr. Martin Altschwager (senior associate, Frankfurt)
IP: Andreas Jauch (senior associate, Frankfurt)
Banking/Finance: Philipp Thimm (PSL, Frankfurt)
IT: Simone Bach (senior associate, Frankfurt)
Tax: Thomas Gierath (partner, Munich), Viktoria Ritter (associate, Munich)
Commercial: Joachim Fröhlich (counsel, Frankfurt), Rebecca Ro-mig (associate, Frankfurt), Brigitte Estner (associate, Munich)
Antitrust: Dr. Christian Burholt (partner, Berlin), Christian Horstkotte (partner, Dusseldorf), Alexander Iken (associate, Berlin)
Employment: Denise Broussal (partner, Paris), Dr. Anna Verena Böhm (counsel, Frankfurt), Cornelius Ziegler (associate, Frankfurt)
Public Law: Anahita Thoms (partner, Düsseldorf), Guillaume Nataf (partner, Paris), Dr. Janet Kerstin Butler (counsel, Berlin), Dr. Katharina Weiner (counsel, Dusseldorf)
Real Estate: Till Pflug (associate, Frankfurt)

Approx. further 125 attorneys in Baker McKenzie offices in Amsterdam, Brussel, Chicago, Istanbul, London, Milan, Prag, Rom, Warsaw und Zurich, New York, Sao Paulo, San Francisco and Washington D.C. as well as Hong Kong, Kuala Lumpur, Melbourne, Singapore, Sydney, Shanghai and Tokyo.

 

Explore Our Newsroom